Designed to be consumed like any other tablet, the oral insulin pill has undergone rigorous testing on various animal models, including mice, rats, and baboons.
Around 425 million individuals globally are affected by diabetes, with about 75 million of them relying on daily insulin injections. Now, a groundbreaking
Hyderabad-based NiedlFree Technologies has developed a needle-free oral insulin spray called Ozulin, offering a painless alternative for diabetes treatment. The company has obtained global patents for Ozulin in over 40 countries and has applied for permission to conduct safety studies. NiedlFree Technologies is also working on oral and nasal sprays for cancer, osteoporosis, and Alzheimer s.